Global Cancer Advancements in Immunotherapy Research

See how CRI is transforming the lives of cancer patients on a global scale.

Want to learn more?

We invite you to download the following educational resources.

CRI Impact Report Infographic cover

Get the Infographic

Explore in-depth insights, at a glance.

Download PDF
CRI FY2023 Impact Report highlights and accomplishments cover

Get the Impact Report

Access FY2023 highlights and accomplishments.

Download PDF
  • $515M

    invested in CRI scientists worldwide since 1953

  • $28.7M

    invested in research grants and fellowships in FY2023

  • 12

    new FDA approvals

01 / Impact

Fueling the Next Wave of Discovery

CRI funds scientists from around the world to advance new avenues of discovery, new technologies, and new ways to analyze and share data about our immune system and it’s power to outsmart cancer.

Thumbnail for Global Cancer Advancements in Immunotherapy Research video

02 / Cancers

Redefining Immunotherapy Success

CRI scientists are accelerating discovery thanks to new technologies that marry data science, bioinformatics, and cancer immunology. To date, there are 4M patients eligible for immunotherapy treatments worldwide.

Video thumbnail - Global Cancer Advancements in Immunotherapy Research - FY2023 - Cancers


cancers now treatable with immunotherapy thanks to the work of CRI

73 awards, 41 institutions, 10 countries

03 / people

Empowering the Best Scientists

CRI’s research is guided by our prestigious Scientific Advisory Council, led by 2018 Nobel Laureate James P. Allison, PhD. Our scientists are leading the charge to advance immunotherapy discovery and shaping the future of the field.

Video thumbnail - Global Cancer Advancements in Immunotherapy Research - FY2023 - People

04 / Research

Recognizing Research Excellence

CRI-funded scientists had 300 publications of news-worthy research in top-tier peer-reviewed academic journals this year.

Video thumbnail - Global Cancer Advancements in Immunotherapy Research - FY2023 - Research



70 years of CRI

05 / Discovery

Unleashing Science with the Power of Data

CRI funded a clinical trial spearheaded by Dr. Valsamo “Elsa” Anagnostou, MD, PhD, from Johns Hopkins, investigating ctDNA technology’s potential. This method, through a blood draw, provides valuable insights into tumor genetics and activity. The trial showed that ctDNA analysis yielded faster, more accurate responses and enhanced predictions for long-term patient outcomes.

Video thumbnail - Global Cancer Advancements in Immunotherapy Research - FY2023 - Discovery

Our Mission

Save more lives by fueling the discovery and development of powerful immunotherapies for all cancers.

This year, CRI proudly celebrates funding 70 years of discovery in cancer immunotherapy. As a top-tier nonprofit that upholds fiscal integrity and transparency, CRI ensures every donation fuels impactful cancer immunotherapy research. Ranked among the top 5% of U.S. charities, we’re dedicated to saving lives worldwide.

Donate Now

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.